Going viral − Virus‐targeting nanobodies for research, diagnostics and therapy
The increasing prevalence of viral diseases represents a major threat for global human health. Nanobodies, small binding fragments derived from camelid heavy‐chain antibodies, offer versatile tools for viral research, diagnostics, and antiviral therapy.
Domenic Ebert, Ulrich Rothbauer
wiley +1 more source
ISAAC: Prior-aligned structural sensitivity auditing for drug–target interaction models
Deep learning models for drug–target interaction (DTI) prediction often achieve strong benchmark performance while relying on input patterns that are not captured by standard accuracy-based evaluation.
Barbara Tarantino +3 more
doaj +1 more source
Exploring drug-target interaction prediction on cold-start scenarios via meta-learning-based graph transformer [PDF]
Predicting drug-target interaction (DTI) is of great importance for drug discovery and development. With the rapid development of biological and chemical technologies, computational methods for DTI prediction are becoming a promising approach.
Zhao, Zhenjiang +5 more
core +1 more source
Unlocking the potential of cell‐permeable nanobodies for intracellular applications
This review outlines current strategies for delivery of nanobodies into cells and highlights recent examples of functional applications. By addressing and manipulating intracellular targets, these molecules hold great potential for treating cancer, respiratory diseases and neurological disorders, making this a vibrant area of research in the biomedical
Mariona Gené‐Verdés +2 more
wiley +1 more source
How structural disorder and polyelectrolyte properties of prothymosin α enable its large interactome
In this review, complexes of the fully disordered and highly negatively charged prothymosin α are collected, described, and discussed. Linked to its poly‐electrostatic character, prothymosin α engages a large interactome through multiple different binding modes ranging from fully disordered complexes to short linear motif (SLiM)‐driven interactions ...
Ketty C. Tamburrini +3 more
wiley +1 more source
AD-MTGraphDTI: Multi-Target Drug–Target Interaction Prediction for Alzheimer’s Disease
Alzheimer’s disease is a multifactorial neurodegenerative disorder whose pathology spans several interacting protein systems, motivating the computational prioritization of compounds active against multiple targets.
Bilal Ahmad +3 more
doaj +1 more source
The UK Medicines and Healthcare products Regulatory Agency received a Coroner’s report that raised concerns about a suspected drug interaction between citalopram and cocaine after the death of a man due to subarachnoid haemorrhage.
core
Mitochondrial translation and coordinated cytosolic translation in metabolic homeostasis and disease
Mitochondrial function depends on coordinated protein production from the nuclear and mitochondrial genomes. This review highlights how cytosolic and mitochondrial translation, mRNA localization, protein import, and respiratory complex assembly are integrated to maintain mitochondrial proteostasis and function.
Boseon Kim +4 more
wiley +1 more source
CCL-DTI: contributing the contrastive loss in drug–target interaction prediction
Background The Drug–Target Interaction (DTI) prediction uses a drug molecule and a protein sequence as inputs to predict the binding affinity value. In recent years, deep learning-based models have gotten more attention.
Alireza Dehghan +4 more
doaj +1 more source
Research Progress on Artificial Intelligence-Driven Drug-Target Interaction Prediction
Drug-target interaction (DTI) is fundamental to novel drug research and development (R &D), playing a critical role in elucidating drug mechanisms of action and improving the cost-effectiveness of drug discovery.
PAN Ting +6 more
doaj +1 more source

